The 3rd and 4th Allogeneic Stem Cell Transplant Patients Discharged

Pediatric patients discharged alongside families and medical team. Photo: T. HIEN

Ho A.D., a 38-month-old from Quang Tri, was the third case to undergo an allogeneic bone marrow transplant. Over the past year, D. had been hospitalized monthly for blood transfusions due to congenital hemolytic anemia. Tests revealed that D.'s older brother was an HLA match (human leukocyte antigen) and could donate bone marrow. The transplant was performed on November 12. Post-transplant recovery included platelet regeneration on day 10 and granulocyte recovery on day 19.

The fourth transplant case was 10-year-old Dang M.A.T., diagnosed with Alpha-Thalassemia, requiring monthly blood transfusions. As T.'s older brother being the donor, and the allogeneic transplant was successfully conducted at the end of November. Following the operation, T. experienced mild neutropenic fever as a complication, with platelet regeneration occurring on day 21 and granulocyte recovery on day 19.

On this occasion, the 40th bone marrow transplant for high-risk neuroblastoma also marked a discharge. The patient, 5-year-old Nguyen P.Q.M. from Tien Giang, successfully underwent the procedure and was discharged from the hospital.

Allogeneic bone marrow transplantation is currently the optimal treatment, offering a chance for complete recovery in children with congenital hemolytic anemia. It also provides promising treatment options for other conditions requiring bone marrow transplants, such as aplastic anemia, congenital immunodeficiencies, and recurrent cancers.

According to Prof. Dr. Pham Nhu Hiep, Director of Hue Central Hospital, the hospital is the third facility in Vietnam to implement this advanced technique for congenital hemolytic anemia patients. With its highly skilled medical team and state-of-the-art equipment, the hospital continues to innovate and apply advanced techniques across various field, including oncology.